APVO: Aptevo Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.23
Enterprise Value ($M) -5.52
Book Value ($M) 4.42
Book Value / Share 8.83
Price / Book 0.50
NCAV ($M) -0.71
NCAV / Share -1.43
Price / NCAV -3.13

Profitability (mra)
Return on Invested Capital (ROIC) -2.38
Return on Assets (ROA) -0.95
Return on Equity (ROE) -1.94

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 1.70

Balance Sheet (mrq) ($M)
Current Assets 10.01
Assets 15.15
Liabilities 10.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 4.99 -52.70
11-08 13G Hudson Bay Capital Management LP 6.96

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 1,555 9,574 16.24
2025-01-30 13,084 37,666 34.74
2025-01-29 12,715 31,209 40.74
2025-01-28 16,396 45,497 36.04

(click for more detail)

Similar Companies
APM – Aptorum Group Limited APRE – Aprea Therapeutics, Inc.
APTO – Aptose Biosciences Inc. ARTL – Artelo Biosciences, Inc.
ASNS – Actelis Networks, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Aptevo Therapeutics Inc